The diagnosis of Fetal Bradycardia LQTS presents a significant challenge in prenatal cardiology. Consequently, a new … Fetal Bradycardia: A Critical Warning for Long QT SyndromeRead more
New Ultrasound Markers Predict Abnormal Karyotype in Early Loss
Early pregnancy loss is a common occurrence, and determining whether the cause is genetic (an abnormal … New Ultrasound Markers Predict Abnormal Karyotype in Early LossRead more
Why Socioeconomic Factors Delay Prenatal CHD Diagnosis
A recent study investigated the critical impact of social and geographical factors on the outcome of … Why Socioeconomic Factors Delay Prenatal CHD DiagnosisRead more
New CT Predictor for Sarcoma Lung Mets Survival
Soft tissue and bone sarcomas frequently metastasize to the lungs. Consequently, early and accurate prognostic assessment … New CT Predictor for Sarcoma Lung Mets SurvivalRead more
DVA Revolutionizes PAE: Less Radiation, Same Quality
Prostatic Artery Embolization (PAE) offers a minimally invasive treatment for Benign Prostatic Hyperplasia (BPH). A prospective … DVA Revolutionizes PAE: Less Radiation, Same QualityRead more
High-Fat Diet’s Hidden Danger: How Liver Cells ‘Revert’ to Cancer
A high-fat diet causes more than just fat overload in the liver. New research from MIT … High-Fat Diet’s Hidden Danger: How Liver Cells ‘Revert’ to CancerRead more
The OB-GYN’s Guide to Chronic Pelvic Pain Management
Chronic pelvic pain (CPP) is a complex, often debilitating condition affecting 15-26% of women worldwide. This … The OB-GYN’s Guide to Chronic Pelvic Pain ManagementRead more
New Data on Maternal RSV Vaccine: Is Preterm Risk Lower?
Maternal RSV vaccination is a key intervention to protect neonates from severe lower respiratory tract disease … New Data on Maternal RSV Vaccine: Is Preterm Risk Lower?Read more
Breakthrough in High-Risk Myeloma: New Dual-Targeting Data
Relapsed or refractory multiple myeloma (RRMM) is difficult to treat, but true Extramedullary Myeloma (EMM) presents … Breakthrough in High-Risk Myeloma: New Dual-Targeting DataRead more
Tividenofusp Alfa: New Hope for Brain-Penetrant MPS II Therapy
Mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome, is a progressive, devastating lysosomal storage … Tividenofusp Alfa: New Hope for Brain-Penetrant MPS II TherapyRead more